News
“Defined about 30 years ago, autoimmune pancreatitis [AIP] remains ... linked to immunoglobulin G4–related disease (IgG4-RD), and type 2 AIP, primarily associated with inflammatory bowel ...
Autoimmune pancreatitis ... subtype of chronic pancreatitis. AIP is best described as the pancreatic manifestation of a systemic fibroinflammatory conditions. The systemic disease of which ...
Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally cracked the confounding code: She had immune disorder IgG4-related disease ...
The drug has become the first to receive FDA approval specifically for treating immunoglobulin G4-related disease (IgG4-RD). LAS VEGAS, April 14, 2025 /PRNewswire/ -- IgG4-related disease (IgG4-RD ...
The regulatory body has now approved Uplizna for the treatment of adults living with immunoglobulin G4-related disease (IgG4-RD), a rare ... adults with a rare autoimmune disease called ...
Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-related ... for an FDA filing in autoimmune disorder ...
Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm autoimmune hemolytic anemia and IgG4-related disease. The FDA has granted ...
Amgen’s Uplizna (inebilizumab-cdon) has been approved by the US Food and Drug Administration (FDA) as the first treatment for adults with immunoglobulin G4-related disease (IgG4-RD), a rare ... in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results